Total Payments
$1,078
2024 Payments
$258.21
Companies
16
Transactions
43
Medicare Patients
38,947
Medicare Billing
$4.6M
Payment Breakdown by Category
Food & Beverage$1,078 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,078 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ORGANOGENESIS INC. | $370.80 | 6 | $0 (2021) |
| ABBVIE INC. | $297.11 | 11 | $0 (2024) |
| Biofrontera Inc. | $96.08 | 7 | $0 (2024) |
| Amgen Inc. | $49.32 | 3 | $0 (2020) |
| GENZYME CORPORATION | $39.49 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $39.07 | 2 | $0 (2023) |
| Galderma Laboratories, L.P. | $35.51 | 3 | $0 (2023) |
| Lilly USA, LLC | $26.30 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $21.81 | 1 | $0 (2024) |
| Incyte Corporation | $18.76 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $258.21 | 9 | ABBVIE INC. ($207.39) |
| 2023 | $171.66 | 9 | GENZYME CORPORATION ($39.49) |
| 2022 | $57.19 | 3 | ABBVIE INC. ($57.19) |
| 2021 | $87.58 | 5 | ORGANOGENESIS INC. ($25.76) |
| 2020 | $71.32 | 4 | Amgen Inc. ($49.32) |
| 2019 | $14.43 | 1 | Biofrontera Inc. ($14.43) |
| 2018 | $366.22 | 8 | Organogenesis Inc. ($306.15) |
| 2017 | $50.97 | 4 | Organogenesis Inc. ($16.89) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Immunology | ||||||
| 04/02/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $13.92 | General |
| Category: DERMATOLOGY | ||||||
| 02/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: IMMUNOLOGY | ||||||
| 02/12/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| Category: DERMATOLOGY | ||||||
| 09/27/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Immunology | ||||||
| 09/15/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Immunology | ||||||
| 08/22/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $14.67 | General |
| Category: DERMATOLOGY | ||||||
| 06/21/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: IMMUNOLOGY | ||||||
| 05/19/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.07 | General |
| Category: Immunology | ||||||
| 05/10/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Immunology | ||||||
| 05/02/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Immunology | ||||||
| 03/20/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| Category: Dermatology | ||||||
| 03/16/2023 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| 10/14/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: IMMUNOLOGY | ||||||
| 03/29/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: IMMUNOLOGY | ||||||
| 01/07/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug), ARAZLO, JUBLIA | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Dermatology | ||||||
| 09/25/2021 | ORGANOGENESIS INC. | Puraply Antimicrobial (Medical Supply) | Food and Beverage | Cash or cash equivalent | $25.76 | General |
| Category: Wound Care | ||||||
| 08/25/2021 | Tactile Systems Technology Inc | Flexitouch Plus (Device), entre | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 07/30/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 81 | 10,317 | 26,047 | $3.7M | $1.2M |
| 2022 | 74 | 9,986 | 23,060 | $3.8M | $1.2M |
| 2021 | 72 | 9,775 | 24,844 | $4.1M | $1.2M |
| 2020 | 68 | 8,869 | 27,313 | $3.7M | $1.0M |
Total Patients
38,947
Total Services
101,264
Medicare Billing
$4.6M
Procedure Codes
295
All Medicare Procedures & Services
295 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 228 | 311 | $380,642 | $123,264 | 32.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 1,106 | 1,498 | $266,733 | $100,761 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 936 | 1,291 | $220,171 | $78,924 | 35.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 480 | 637 | $240,297 | $78,441 | 32.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,038 | 2,678 | $449,305 | $77,987 | 17.4% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 134 | 220 | $158,853 | $72,764 | 45.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 1,081 | 11,409 | $278,395 | $53,298 | 19.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,123 | 1,598 | $185,521 | $44,048 | 23.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 891 | 1,231 | $182,899 | $43,948 | 24.0% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 42 | 44 | $63,994 | $26,880 | 42.0% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 42 | 42 | $66,360 | $25,475 | 38.4% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 77 | 80 | $45,622 | $24,187 | 53.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 255 | 312 | $92,357 | $23,691 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 246 | 246 | $49,254 | $17,053 | 34.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 73 | 77 | $66,633 | $16,992 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 170 | $34,116 | $16,025 | 47.0% |
| 14061 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 20 | 20 | $45,000 | $15,674 | 34.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 70 | 92 | $31,589 | $15,313 | 48.5% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 146 | 170 | $45,970 | $14,175 | 30.8% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 117 | 150 | $48,573 | $12,955 | 26.7% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 108 | 137 | $34,738 | $12,759 | 36.7% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 67 | 68 | $44,200 | $11,566 | 26.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 74 | 87 | $30,464 | $10,162 | 33.4% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 12 | 13 | $20,837 | $9,717 | 46.6% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 11 | 12 | $19,169 | $9,660 | 50.4% |
About Dr. Martin Salm, M.D
Dr. Martin Salm, M.D is a Dermatology healthcare provider based in Stateline, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1518152420.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martin Salm, M.D has received a total of $1,078 in payments from pharmaceutical and medical device companies, with $258.21 received in 2024. These payments were reported across 43 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,078).
As a Medicare-enrolled provider, Salm has provided services to 38,947 Medicare beneficiaries, totaling 101,264 services with total Medicare billing of $4.6M. Data is available for 4 years (2020–2023), covering 295 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties MOHS-Micrographic Surgery, Dermatopathology
- Location Stateline, NV
- Active Since 09/13/2007
- Last Updated 09/01/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518152420
Products in Payments
- Apligraf (Biological) $306.15
- SKYRIZI (Biological) $293.22
- AMELUZ (Drug) $58.11
- Enbrel (Biological) $49.32
- DUPIXENT (Biological) $39.49
- Sotyktu (Drug) $39.07
- Ameluz (Drug) $37.97
- TALTZ (Drug) $26.30
- Puraply Antimicrobial (Medical Supply) $25.76
- Puraply (Medical Supply) $22.00
- TREMFYA (Drug) $21.81
- OPZELURA (Drug) $18.76
- DUOBRII (Drug) $18.49
- Apligraf (Device) $16.89
- Flexitouch Plus (Device) $16.74
- DYSPORT (Biological) $13.97
- EUCRISA (Drug) $13.46
- Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% (Drug) $11.69
- PICATO (Drug) $11.23
- EPIDUO FORTE (Drug) $10.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.